Presenters William Robinson, MD, PhD, and Liana Fraenkel, MD, MPH, shared several noteworthy developments in basic and clinical science, as well as outcomes from multiple studies.
In a Sunday session that also featured a pulmonologist, rheumatologist Flavia V. Castelino, MD, discussed how therapies targeting interstitial lung disease affect the extrapulmonary features of autoimmune disease.
Doruk Erkan, MD, MPH, and Jason S. Knight, MD, PhD, will discuss the clinical manifestations, diagnostic considerations, management strategies, and future research opportunities for patients with MAPS.
Excess adiposity is a risk factor for rheumatologic diseases. Derin Karacabeyli, MD, Kim M. Huffman, MD, PhD, and Stephen Messier, PhD, will explore adipose tissue biology and adipokine-mediated mechanisms.